Recent Advances in Nanocarriers for Pancreatic Cancer Therapy reviews thriving strategies concerning pancreatic cancer therapy, thoroughly describing the most recent developments in emerging modern drug delivery systems focused on, and derived from, nanotechnology. By providing a holistic understanding of the molecular pathways, conventional therapy and novel nanocarriers mediated drug delivery against pancreatic cancer, this work can be considered a complete package. The book offers a solution to the dissemination of data from a broad range of resources by providing an overview of the molecular pathways and conventional therapy of pancreatic cancer, the application of various nanocarriers, and more.
This book equips scientists, clinicians and students to make rational treatment approaches based on nanomedicine for improving and extending the human life against pancreatic cancer.
- Explains the complete journey of nanomedicine-based approaches in pancreatic cancer drug delivery from fundamental to most recent applications
- Provides information about various approaches for the diagnosis and treatment of pancreatic cancer using the latest advancement in cutting-edge nanomedical technologies
- Discusses the perspectives of the technologies explored to date based upon the findings outlined in highly organized tables, illustrative figures and flow charts for easy consult and comprehension
Part A. Overview, molecular pathways and conventional therapy of pancreatic cancer 1. Introduction: An Overview of the anatomy and physiology of the pancreas
2. Different drug / drug combination based therapies pertaining to pancreatic cancer
Part B. Application of various nanocarriers for the management of pancreatic cancer 3. Nanotechnology potential in treatment and overcoming pancreatic cancer resistance
4. Precision medicine for treatment of pancreatic cancer
5. Hydrogel based drug delivery for pancreatic cancer
6. Nanoemulsions based drug delivery for pancreatic cancer
7. Liposomes and niosomes based drug delivery for pancreatic cancer
8. Micelles based drug delivery for pancreatic cancer
9. Theranostic Nanoparticles in pancreatic cancer
10. Polymeric nanoparticles based drug delivery for pancreatic cancer
11. Metallic nanoparticles based drug delivery for pancreatic cancer
12. Solid lipid nanoparticles based drug delivery for pancreatic cancer
13. Recent update on solid lipid nanoparticles mediated drug delivery for pancreatic cancer
14. Dendrimers and carbon nanotubes based drug delivery for pancreatic cancer
Part C. Recent advances and future prospective for pancreatic cancer 15. Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer
16. Clinical practice guidelines for interventional treatment of pancreatic cancer
17. Gene therapy and aptamer mediated nano therapy for pancreatic cancer
18. Photodynamic therapy for pancreatic cancer
19. Future prospect of nano based drug delivery approaches against pancreatic cancer and expected pitfalls of the technology
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as USERN Laureate award, most prestigious SERB-Ramanujan Fellowship Award. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
Prof. Neelima Gupta presently works as a vice chancellor of Dr. Harisingh Gour Vishwavidyalaya Sagar (A Central University), Madhya Pradesh, India. She is a global leader having visited the five continents of the world, including countries like the United States, UK, Japan, Germany, France, Poland, Hong Kong, Thailand, Egypt, China, Singapore, Egypt, and Australia. She is the recipient of more than 70 awards and has published 216 research papers, is the author/editor of 9 books, and has adjudicated more than 150 PhD theses in India and abroad. She has worked extensively on parasite taxonomy, aquatic toxicology, and pollution load of the Ramganga (Kalagarh to Kannauj) and Ganga (Haridwar to Kanpur) rivers, and fish health. Research contributions include morpho-molecularSEM taxonomy and protein profile based on 60 species of 22 genera (51 new species, 3 subspecies), and 7 GenBank submissions (GenBank: NIH genetic sequence database). She is a pioneer in the Atmanirbhar Bharat Movement launched by the Government of India.
Biežāk uzdotie jautājumi par e-grāmatām